Skip to main content
Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
0.9431
+0.1007 (11.95%)
Nov 13, 2026, 4:00 PM EST - Market closed

Perspective Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Market Capitalization
1142042161133544
Market Cap Growth
-27.74%-5.18%91.16%221.19%-19.99%-61.12%
Enterprise Value
-8434-4898-19-14
Last Close Price
0.942.753.194.022.473.09

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Forward PE
-21.5121.5121.5121.5121.51
PS Ratio
517.67231.26148.2878.656.49-
PB Ratio
0.370.990.741.500.640.72
P/TBV Ratio
0.451.220.90147.820.640.72

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
EV/Sales Ratio
-38.02-68.42--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Debt / Equity Ratio
0.010.020.010.03-0.01
Net Debt / Equity Ratio
-0.67-0.68-0.77-0.09-0.80-0.90
Net Debt / EBITDA Ratio
1.561.283.460.175.169.02
Net Debt / FCF Ratio
1.431.493.070.184.106.94
Asset Turnover
0.000.000.010.02--
Quick Ratio
5.095.0812.530.6714.4725.38
Current Ratio
5.185.1712.681.0817.0726.18
Return on Equity (ROE)
-45.86%-41.65%-42.82%-57.70%--9.79%
Return on Assets (ROA)
-24.92%-23.34%-19.02%-32.81%--5.95%
Return on Capital Employed (ROCE)
-40.40%-47.70%-20.70%-49.80%-16.00%-10.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Earnings Yield
-124.25%-50.44%-36.77%-41.23%-30.64%-16.57%
FCF Yield
-121.87%-46.59%-33.72%-33.68%-30.42%-18.17%
Buyback Yield / Dilution
-43.81%-14.57%-140.72%-88.38%-0.06%-36.73%
SEC Filings: 10-K · 10-Q